Journal Club

Sorafenib extends PFS for refractory desmoid tumors

Publish date: December 19, 2018

The oral tyrosine kinase inhibitor was associated with durable responses and a high progression-free survival rate in patients with refractory or...

Publish date: October 23, 2018

Tyrosine kinase inhibitors and immune checkpoint inhibitors show encouraging results in the treatment of alveolar soft part sarcoma

Publish date: September 18, 2018

Investigators planning phase 2 studies after phase 1b results demonstrated tolerability and efficacy with the combination of olaparib and...

Two new fusion partners for the USP6 gene were found using AMP-based targeted next-generation sequencing.

Analysis of the sequence context surrounding chromoplexy breaks may provide clues and potentially point to a therapeutic vulnerability that could...

Publish date: May 14, 2018

Publish date: May 3, 2018

Next-generation sequencing results might prove useful for guiding targeted therapy that could improve the treatment outcomes of patients with...